KELLY SOREL
** ****** **, ***** **, ***** · 617-***-**** · **********@*****.***
EDUCATION
MASSACHUSETTS INSTITUTE OF TECHNOLOGY, Cambridge, MA Jun. 2021
Master of Applied Science in Supply Chain Management
Supply Chain Management Program
OHIO UNIVERSITY, Athens, OH 2000 – 2004
Bachelor of Science: Chemistry & Biochemistry Department
Major: Forensic Chemistry
EXPERIENCE
WAVE LIFE SCIENCES, Lexington, MA Jul. 2021 – present
Associate Director, Clinical Supply Chain
Provided sole operational oversight to ensure timely delivery of released and approved IMP and ancillaries for all clinical trials. This included:
-Collaborating with CMC, Global Supply Chain, Regulatory, Clinical Operations, Quality, and Project Team customers
-Forecasting demand
-Overseeing availability of IMP and ancillaries at depots and sites
-Performing selection, set-up, and management of IRT, Drug Distribution, and Translation vendors
-Managing temperature excursions and any other quality-related topics
Developed and maintained IMP labels and Pharmacy Manuals for all clinical trials
Identified requirements for site pharmacies, and vetted pharmacies for participation in clinical trials
Acted as SME during regulatory inspections
Collaborated on SOP development and process improvement
SANOFI, Framingham, MA Feb. 2017 – Jun. 2021
Clinical Supply Chain Project Leader
Led Clinical Supplies Project Team, which included up to 15 representatives from demand planning/material movement, trial supply operations management, quality and packaging/labeling. Notable projects included:
-A top 5 company priority project with 5 rare disease indications and seven Phase 1, two Phase 2, and twenty-two Phase 3 trials in the clinical development plan
-Post-market global pediatric study for a top 3 profitable drug for company
-21 externally-sponsored research studies, requiring collaboration outside of Sanofi
Represented Clinical Supplies at the Project Team level and within CMC team; acted as a single interface with regulatory, clinical operations, quality and project team customers
Generated service agreements (containing technical specifications for packaging/labeling, IMP demand, timelines and related costs); managed any change impacting the allocated budget; revised business plan and service agreement accordingly
Directed risk management, which required leadership and a comprehensive understanding of the disease indication, trial design and specificities to the drug and patient population. This included:
-Understanding of all regulatory activities required due to changes in clinical study design, CMC attributes, and/or guidelines
-Pro-active planning and implementation of back-up plans
ALNYLAM, Cambridge, MA Aug. 2014 – Jan. 2017
Supply Chain Planner
Coordinated IMP for multiple global clinical trials, requiring management of label creation, packaging/labeling and distribution
Communicated and updated clinical supply requirements on a study and project level to Supply Chain Management, and ensured seamless coordination of demand and supply through partnerships with quality and clinical operations
Ensured changes in supply configuration, trial design, enrollment timelines, manufacturing availability and regulatory requirements were captured within the supply and demand plan
Developed strong internal relationships with stakeholders to ensure customer satisfaction and continuity of supply
SHIRE HUMAN GENETIC THERAPIES, Lexington, MA Nov. 2006 – Aug. 2014
Senior Planner
Production Control Specialist
Manufacturing Technician
ACHIEVEMENTS
MITx MicroMasters program certificate
-MITx MicroMasters program in Supply Chain Management, Massachusetts Institute of Technology on edX
Developed competency in Supply Chain theory and practice through 500 hours of online coursework
Created models and solved problems in SC analytics, design, dynamics and related technologies